Mink Therapeutics Debt
INKT Stock | USD 8.49 0.51 6.39% |
At this time, Mink Therapeutics' Debt To Assets are comparatively stable compared to the past year. Debt Ratio is likely to gain to 16.54 in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 38.8 M in 2025. . Mink Therapeutics' financial risk is the risk to Mink Therapeutics stockholders that is caused by an increase in debt.
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 11.06 | Current Value 16.54 | Quarterly Volatility 4.98969707 |
Mink |
Mink Therapeutics Bond Ratings
Mink Therapeutics financial ratings play a critical role in determining how much Mink Therapeutics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Mink Therapeutics' borrowing costs.Piotroski F Score | 4 | Poor | View |
Beneish M Score | (8.44) | Unlikely Manipulator | View |
Mink Therapeutics Debt to Cash Allocation
Mink Therapeutics currently holds 22.61 M in liabilities. Mink Therapeutics has a current ratio of 1.71, which is within standard range for the sector. Note, when we think about Mink Therapeutics' use of debt, we should always consider it together with its cash and equity.Mink Therapeutics Total Assets Over Time
Mink Therapeutics Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Mink Therapeutics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Mink Therapeutics Debt Ratio | 1654.0 |
Mink Therapeutics Corporate Bonds Issued
Mink Short Long Term Debt Total
Short Long Term Debt Total |
|
Understaning Mink Therapeutics Use of Financial Leverage
Mink Therapeutics' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Mink Therapeutics' current equity. If creditors own a majority of Mink Therapeutics' assets, the company is considered highly leveraged. Understanding the composition and structure of Mink Therapeutics' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Last Reported | Projected for Next Year | ||
Short and Long Term Debt Total | 50.4 M | 38.8 M | |
Net Debt | -3 M | -2.9 M | |
Long Term Debt | 50.4 M | 38.8 M | |
Short Term Debt | 4.3 M | 3.8 M | |
Net Debt To EBITDA | 0.15 | 0.14 | |
Debt To Equity | (0.94) | (0.98) | |
Interest Debt Per Share | 0.01 | 0.01 | |
Debt To Assets | 11.06 | 16.54 | |
Long Term Debt To Capitalization | (5.01) | (5.27) | |
Total Debt To Capitalization | (5.01) | (5.27) | |
Debt Equity Ratio | (0.94) | (0.98) | |
Debt Ratio | 11.06 | 16.54 | |
Cash Flow To Debt Ratio | (0.17) | (0.18) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.